Search Results - "Devkota, M. K."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Efficacy of Saccharomyces boulardii CNCM I-745 probiotic drug in the prevention and treatment of diarrhea in hospitalized patients with new coronavirus infection COVID-19 by Maev, Igor V., Andreev, Dmitry N., Sokolov, Philipp S., Fomenko, Aleksei К., Devkota, Mikhail K., Andreev, Nikolai G., Zaborovsky, Andrew V.

    Published in Terapevtic̆eskii arhiv (22-11-2022)
    “…Aim. To evaluate the efficacy of Saccharomyces boulardii (S. boulardii) CNCM I-745 probiotic drug in preventing and treating diarrhea in hospitalized patients…”
    Get full text
    Journal Article
  2. 2

    Evaluation of the efficacy and safety of remdesivir in hospitalized patients with a new coronavirus infection COVID-19: data from a Russian university clinic by Yanushevich, O. O., Maev, I. V., Krikheli, N. I., Levchenko, O. V., Andreev, D. N., Sokolov, P. S., Fomenko, A. K., Devkota, M. K., Andreev, N. G., Zaborovsky, A. V., Shefer, D. I.

    Published in Medicinskij sovet (06-10-2022)
    “…Introduction. The use of remdesivir in patients with the new coronavirus infection COVID-19 is known to improve the prognosis of the disease. But there is not…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5